FDA Inspection
bB BIOCHEM LABORATORIES INC.bB BIOCHEM LABORATORIES INC. – FDA Inspection, Dec 18, 2017
Record Details
This FDA Inspection record concerns bB BIOCHEM LABORATORIES INC., with an inspection on December 18, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Bryan A. Galvez (FDA Associated Person)
- Christopher D. Washington (Issuing Officer)
View Company Profile
ID · f56a9abd-5706-4371-91ac-73d6dfa99fc3
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1035271
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.87Retest of approved components/containers/closures
- 21 CFR 211.84(a)Components withheld from use pending release
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.166(a)Lack of written stability program
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.